Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 18, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US

PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides...
April 02, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Coverage of Its Thyroid Assays by Blue Shield of California

PARSIPPANY, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
March 28, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Agreement with Acupath Laboratories

PARSIPPANY, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company...
March 20, 2018 08:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Expansion of LabCorp National Agreement

PARSIPPANY, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
March 15, 2018 16:01 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2017 Financial Results, Business Progress Against Plan and Recent Accomplishments

Revenue for the Quarter Grew 40% over the Comparable Prior Year Quarter and 21% for the Full Year, Raising $30 Million in Equity and Significantly Improving Balance Sheet and Cash Position,...
March 14, 2018 14:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Timing of Earnings Release and Investor Conference Call

PARSIPPANY, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company”), a fully integrated commercial and bioinformatics company that provides...
March 08, 2018 08:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Additional Coverage of Thyroid Tests

PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
February 26, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Horizon Blue Cross Blue Shield of New Jersey to Cover Interpace’s Molecular Thyroid Tests

PARSIPPANY, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
February 22, 2018 13:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics’ CEO Interviewed on The RedChip Money Report

PARSIPPANY, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
February 12, 2018 09:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present Data on Thyroid, Pancreatic, and Lung Assays

PARSIPPANY, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...